sub-regional radiomics model(English)

• a novel tumor biomarker in predicting the response of patients with NSCLC treated with immune checkpoint inhibitors
• NSCLC, PD-L1, TMB
• Biomarker, Oncology
• https://doi.org…967-024-04904-6